Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study 22. januar 2022Børn & Sundhed, Forebyggelse, Præventive Strategier & Immunitet, Samfund, Miljø, Historie & Fortid(link-samling), Sundheds-emner(link-samling), Videnskabelige ArtiklerIngen kommentarerJon Ch. Henningsen
